Tevogen Bio Holdings Stock Current Asset
| TVGN Stock | 1.31 0.06 4.38% |
Tevogen Bio Holdings fundamentals help investors to digest information that contributes to Tevogen Bio's financial success or failures. It also enables traders to predict the movement of Tevogen Stock. The fundamental analysis module provides a way to measure Tevogen Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tevogen Bio stock.
As of the 30th of November 2024, Non Current Assets Total is likely to drop to about 15.8 M. In addition to that, Other Current Assets is likely to drop to 2,376. Tevogen |
Tevogen Bio Holdings Company Current Asset Analysis
Tevogen Bio's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Tevogen Current Asset Historical Pattern
Today, most investors in Tevogen Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tevogen Bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tevogen Bio current asset as a starting point in their analysis.
Tevogen Bio Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Tevogen Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Tevogen Bio Holdings has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Tevogen Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tevogen Bio's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tevogen Bio could also be used in its relative valuation, which is a method of valuing Tevogen Bio by comparing valuation metrics of similar companies.Tevogen Bio is currently under evaluation in current asset category among its peers.
Tevogen Fundamentals
| Return On Asset | -0.83 | ||||
| Current Valuation | 258.98 M | ||||
| Shares Outstanding | 164.61 M | ||||
| Shares Owned By Insiders | 96.61 % | ||||
| Shares Owned By Institutions | 4.58 % | ||||
| Number Of Shares Shorted | 774.71 K | ||||
| EBITDA | 188.71 K | ||||
| Net Income | (67.33 K) | ||||
| Total Debt | 1.63 M | ||||
| Cash Flow From Operations | (1.38 M) | ||||
| Short Ratio | 0.07 X | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 164.61 M | ||||
| Total Asset | 17.04 M | ||||
| Retained Earnings | (17.38 M) | ||||
| Working Capital | (2.65 M) | ||||
| Net Asset | 17.04 M |
About Tevogen Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tevogen Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tevogen Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tevogen Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tevogen Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tevogen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Tevogen Stock
Moving against Tevogen Stock
| 0.84 | ELAN | Elanco Animal Health | PairCorr |
| 0.7 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.69 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.67 | HLN | Haleon plc | PairCorr |
| 0.57 | ZTS | Zoetis Inc | PairCorr |
The ability to find closely correlated positions to Tevogen Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tevogen Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tevogen Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tevogen Bio Holdings to buy it.
The correlation of Tevogen Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tevogen Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tevogen Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tevogen Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Tevogen Bio Piotroski F Score and Tevogen Bio Altman Z Score analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.